Robert S. Epstein

Robert S. Epstein, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Veracyte, Inc., Illumina, Inc. and Fate Therapeutics Inc. The record holds 18 filings, for trades running from 25 May 2021 to 11 June 2026.

Sales make up the whole of the open-market record (1 sale, €379k). Other entries cover 14 share grants and 3 option exercises. 2026 to date brings no purchases and 1 sale.

The record was last updated on 15 June 2026 with a share grant in Veracyte, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.